Dronabinol for Post-operative Pain After Lumbar Fusion
Status:
Enrolling by invitation
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Impact of 2.5mg of oral Dronabinol daily versus placebo on post-operative opioid consumption
on patients aged 18 to 65 years old undergoing 1 to 3 level posterolateral fusion